logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Masafumi Fukagawa

Tokai University

75H指数
1.2K论文数
2.2W被引数
收录论文 212
发表时间
logo
Effect of tenapanor on bowel movements in hemodialysis patients with hyperphosphatemia based on a pooled post hoc analysis of three clinical trials基于三项临床试验的合并事后分析探讨铁碳酸钠对高磷血症血液透析患者肠道运动的影响
errScientific Reports
IF3.9
err2026-08-06
err0
errOAAI
errShin Tokunaga; Masatomo Taniguchi; Shinji Asada; Masafumi Fukagawa; Tadao Akizawa
err分享
err收藏
Growth Failure Associated With Parathyroid Hormone Levels in Pediatric Dialysis Patients: A Nationwide Cohort Study与甲状旁腺激素水平相关的儿童透析患者生长迟缓：一项全国性队列研究
errKidney Medicine
IF3.4
err2025-12-15
err0
errOAAI
errTakahiro Imaizumi; Takuo Kubota; Hirotaka Komaba; Masanori Abe; Norio Hanafusa; Takayuki Hamano; Masafumi Fukagawa
err分享
err收藏
Upacicalcet preserves albumin levels in hemodialysis patients with secondary hyperparathyroidism: a post-hoc analysis of a randomized trialUpacicalcet能维持行血液透析且患有继发性甲状旁腺功能亢进症患者的白蛋白水平：一项随机试验的回顾性分析
errNephrology Dialysis Transplantation
IF5.6
err2025-10-01
err0
errOAAI
errKomaba, Hirotaka; Akari, Seigo; Otsuki, Takeju; Ono, Yoshiyuki; Fukagawa, Masafumi
err分享
err收藏
Chronic Limb-Threatening Ischemia in Patients Undergoing Hemodialysis: Epidemiology, Risk Factors, and Outcomes
errJOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS
IF2.8
err2025-10-01
err1
PREAI
errKomaba, Chieko; Komaba, Hirotaka; Imagawa, Kotaro; Hida, Miho; Suga, Takao; Kakuta, Takatoshi; Fukagawa, Masafumi; Akamatsu, Tadashi
err分享
err收藏
Lack of Association between Dietary Fiber Intake and Kidney Failure among Patients with CKD: the CKD-JAC study膳食纤维摄入与CKD患者肾衰竭之间缺乏关联：CKD-JAC研究
errJournal of Renal Nutrition
IF3.2
err2025-06-28
err0
PREAI
errKoki Hattori; Yusuke Sakaguchi; Yoshitaka Isaka; Takahiro Imaizumi; Shoichi Maruyama; Masafumi Fukagawa
err分享
err收藏
Association of serum phosphate levels and statin use with cardiovascular events in Japanese patients on chronic haemodialysis: a post-hoc analysis of the LANDMARK trial血清磷酸盐水平及他汀类药物使用与日本慢性血液透析患者心血管事件的关系：LANDMARK试验的事后分析
errCLINICAL KIDNEY JOURNAL
IF4.6
err2025-06-01
err0
errOAAI
errSaito, Tomohiro; Mizobuchi, Masahide; Yamakawa, Akane; Kagimura, Tatsuo; Ogata, Hiroaki; Fukagawa, Masafumi; Hirakata, Hideki; Akizawa, Tadao; Honda, Hirokazu
err分享
err收藏
Corrigendum to “Lower Parathyroid Hormone Levels are Associated With Reduced Fracture Risk in Japanese Patients on Hemodialysis” [Kidney International Reports Volume 9, Issue 10, October 2024, Pages 2956-2969]勘误：“日本血液透析患者中较低的甲状旁腺激素水平与骨折风险降低相关”【《肾脏国际报告》第9卷，第10期，2024年10月，第2956-2969页】
errKidney International Reports
IF5.7
err2025-05-14
err0
errOAAI
errHirotaka Komaba; Takahiro Imaizumi; Takayuki Hamano; Naohiko Fujii; Masanori Abe; Norio Hanafusa; Masafumi Fukagawa
err分享
err收藏
Fibroblast Growth Factor 23, Endogenous Erythropoietin, Erythropoiesis-Stimulating Agents, and Erythropoietin Resistance in Hemodialysis Patients血液透析患者的成纤维细胞生长因子23，内源性促红细胞生成素，促红细胞生成刺激剂和促红细胞生成素抵抗
errAMERICAN JOURNAL OF NEPHROLOGY
IF3.2
err2025-02-20
err0
PREAI
errHamano, Naoto; Komaba, Hirotaka; Tanaka, Hisae; Takahashi, Hiroo; Takahashi, Yuichiro; Hyodo, Toru; Hida, Miho; Suga, Takao; Wada, Takehiko; Kakuta, Takatoshi; Fukagawa, Masafumi
err分享
err收藏
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study
errCLINICAL KIDNEY JOURNAL
IF4.6
err2025-01-13
err1
errOAAI
errImaizumi, Takahiro; Komaba, Hirotaka; Hamano, Takayuki; Nangaku, Masaomi; Murotani, Kenta; Hasegawa, Takeshi; Fujii, Naohiko; Nitta, Kosaku; Isaka, Yoshitaka; Wada, Takashi; Maruyama, Shoichi; Fukagawa, Masafumi
err分享
err收藏
Lower Parathyroid Hormone Levels are Associated With Reduced Fracture Risk in Japanese Patients on Hemodialysis
errKIDNEY INTERNATIONAL REPORTS
IF5.7
err2024-10-01
err3
errOAAI
errKomaba, Hirotaka; Imaizumi, Takahiro; Hamano, Takayuki; Fujii, Naohiko; Abe, Masanori; Hanafusa, Norio; Fukagawa, Masafumi
err分享
err收藏
Long-Term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-Label 52-Week Study
errAMERICAN JOURNAL OF NEPHROLOGY
IF3.2
err2024-09-19
err6
errOAAI
errHamano, Takayuki; Koiwa, Fumihiko; Isaka, Yoshitaka; Yokoyama, Keitaro; Fukagawa, Masafumi; Inagaki, Yosuke; Watanabe, Yukihisa S.; Honda, Daisuke; Akizawa, Tadao
err分享
err收藏
Results of the EPISODE trial plead for reasonable practice-based serum phosphate lowering in patients on dialysis
errKIDNEY INTERNATIONAL
IF12.6
err2024-08-01
err1
PREAI
errHamano, Takayuki; Fukagawa, Masafumi
err分享
err收藏
Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPS
errKIDNEY INTERNATIONAL REPORTS
IF5.7
err2024-04-01
err7
errOAAI
errYamamoto, Suguru; Jorgensen, Hanne Skou; Zhao, Junhui; Karaboyas, Angelo; Komaba, Hirotaka; Vervloet, Marc; Mazzaferro, Sandro; Cavalier, Etienne; Bieber, Brian; Robinson, Bruce; Evenepoel, Pieter; Fukagawa, Masafumi
err分享
err收藏
Proton pump inhibitors and hyporesponsiveness to erythropoiesis stimulating agents in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study
errAMERICAN JOURNAL OF NEPHROLOGY
IF3.2
err2023-11-07
err1
errOAAI
errNakashima, Akio; Miyawaki, Yoshia; Komaba, Hirotaka; Kurita, Noriaki; Onishi, Yoshihiro; Yokoo, Takashi; Fukagawa, Masafumi
err分享
err收藏
Long-term safety and decrease of pill burden by tenapanor therapy: a phase 3 open-label study in hemodialysis patients with hyperphosphatemia
errSCIENTIFIC REPORTS
IF3.9
err2023-11-04
err4
errOAAI
errKoiwa, Fumihiko; Sato, Yu; Ohara, Meiko; Nakanishi, Kaoru; Fukagawa, Masafumi; Akizawa, Tadao
err分享
err收藏
Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism
errKIDNEY INTERNATIONAL REPORTS
IF5.7
err2023-11-01
err4
errOAAI
errNi, Zhaohui; Liang, Xinling; Wu, Chia-Chao; Jin, Kyubok; Kim, Yong-Lim; Lu, Kuo-Cheng; Chan, Tak Mao; Fukagawa, Masafumi; Kinoshita, Jun; Nagai, Chisato; Kojima, Masahiro; Yu, Xueqing
err分享
err收藏
Randomized Study of Tenapanor Added to Phosphate Binders for Patients With Refractory Hyperphosphatemia
errKIDNEY INTERNATIONAL REPORTS
IF5.7
err2023-11-01
err4
errOAAI
errNitta, Kosaku; Itoyama, Saki; Ikejiri, Kazuaki; Kinoshita, Jun; Nakanishi, Kaoru; Fukagawa, Masafumi; Akizawa, Tadao
err分享
err收藏
Tenapanor for the Treatment of Hyperphosphatemia in Japanese Hemodialysis Patients: A Randomized Phase 3 Monotherapy Study With an Up-titration Regimen
errAMERICAN JOURNAL OF KIDNEY DISEASES
IF8.2
err2023-11-01
err7
errOAAI
errFukagawa, Masafumi; Urano, Natsuki; Ikejiri, Kazuaki; Kinoshita, Jun; Nakanishi, Kaoru; Akizawa, Tadao
err分享
err收藏
Active Vitamin D Use and Fractures in Hemodialysis Patients: Results from the International DOPPS
errJOURNAL OF BONE AND MINERAL RESEARCH
IF5.9
err2023-11-01
err4
errOAAI
errKomaba, Hirotaka; Zhao, Junhui; Karaboyas, Angelo; Yamamoto, Suguru; Dasgupta, Indranil; Hassan, Mohamed; Zuo, Li; Christensson, Anders; Combe, Christian; Robinson, Bruce M.; Fukagawa, Masafumi
err分享
err收藏
Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism A Randomized Placebo-Controlled Trial
errCLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
IF7.1
err2023-09-11
err11
errOAAI
errShigematsu, Takashi; Koiwa, Fumihiko; Isaka, Yoshitaka; Fukagawa, Masafumi; Hagita, Keiko; Watanabe, Yukihisa S.; Honda, Daisuke; Akizawa, Tadao
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
M
Mark Woodward
H 指数: 176 · 论文数: 1.8K
M
Marcello Tonelli
H 指数: 162 · 论文数: 996
G
Glenn M. Chertow
H 指数: 151 · 论文数: 1.2K
K
Kai‐Uwe Eckardt
H 指数: 117 · 论文数: 895
V
Vlado Perkovic
H 指数: 116 · 论文数: 782
查看更多